C/EBPα regulates CRL4cdt2-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint

Cell Cycle

Volumn 13, Issue 22, 2014, Pages 3602-3610

  Hall, Jonathan R ^a   Bereman, Michael S ^a   Nepomuceno, Angelito I ^a   Thompson, Elizabeth A ^a   Muddiman, David C ^a   Smart, Robert C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA; PROTEIN P21; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 CRL4 CDT2; UNCLASSIFIED DRUG; DTL PROTEIN, HUMAN; NUCLEAR PROTEIN; P21 ACTIVATED KINASE; PAK1 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; COMPLEX FORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; G1 PHASE CELL CYCLE CHECKPOINT; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; ULTRAVIOLET B RADIATION; ANIMAL; CELL CYCLE CHECKPOINT; GENETICS; METABOLISM; RADIATION RESPONSE; ULTRAVIOLET RADIATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL CYCLE CHECKPOINTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINTS; KERATINOCYTES; MICE; NUCLEAR PROTEINS; P21-ACTIVATED KINASES; PROTEOLYSIS; UBIQUITIN-PROTEIN LIGASES; ULTRAVIOLET RAYS;

EID: 84919933440     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.962957     Document Type: Article

References (54)

1. American Cancer Society. Cancer Facts and Figures 2013. Atlanta: American Cancer Society. http://cancer. org
2. Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997; 13:410-4; PMID:9351343; http://dx.doi.org/10.1016/S0168-9525(97)01246-8
3. de Gruijl FR, van Kranen HJ, Mullenders LH. UVinduced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol 2001; 63:19-27; PMID:11684448; http://dx.doi.org/ 10.1016/S1011-1344(01)00199-3
4. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991; 88:10124-8; PMID:1946433; http://dx.doi.org/ 10.1073/pnas.88.22.10124
5. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432:316-23; PMID:15549093; http://dx.doi.org/10.1038/nature03097
6. Ikehata H, Ono T. The mechanisms of UV mutagenesis. J Radiat Res 2011; 52:115-25; PMID:21436607; http://dx.doi.org/10.1269/jrr.10175
7. Bartek J, Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Bio 2001; 13:738-47; PMID:11698191; http://dx.doi. org/10.1016/S0955-0674(00)00280-5
8. Niida H, Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis 2006; 21:3-9; PMID:16314342; http://dx.doi.org/10.1093/mutage/gei063
9. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9:935-44; PMID:7774811; http://dx.doi.org/10.1101/gad.9.8.935
10. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010; 22:1003-12; PMID:20100570; http://dx.doi.org/10.1016/j. cellsig.2010.01.013
11. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25; PMID:8242752; http://dx.doi.org/10.1016/0092-8674(93)90500-P
12. Gartel AL, Tyner AL. Transcriptional regulation of the p21(WAF1/CIP1) gene. Expl Cell Res 1999; 246:280-9; PMID:9925742; http://dx.doi.org/ 10.1006/excr.1998.4319
13. Gu Y, Turck CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993; 366:707-10; PMID:8259216; http://dx. doi.org/10.1038/366707a0
14. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75:805-16; PMID:8242751; http://dx.doi.org/ 10.1016/0092-8674(93)90499-G
15. Poon RY, Jiang W, Toyoshima H, Hunter T. Cyclindependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UVinduced DNA damage. J Biol Chem 1996; 271:13283-91; PMID:8662825; http://dx.doi.org/10.1074/ jbc.271.23.13706
16. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-4; PMID:8259214; http:// dx.doi.org/10.1038/366701a0
17. Gottifredi V, McKinney K, Poyurovsky MV, Prives C. Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J Biol Chem 2004; 279:5802-10; PMID:14597617; http://dx.doi.org/ 10.1074/jbc.M310373200
18. Shivji MK, Grey SJ, Strausfeld UP, Wood RD, Blow JJ. Cip1 inhibits DNA replication but not PCNAdependent nucleotide excision-repair. Curr Biol 1994; 4:1062-8; PMID:7704570; http://dx.doi.org/10.1016/ S0960-9822(00)00244-X
19. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369:574-8; PMID:7911228; http://dx.doi.org/ 10.1038/369574a0
20. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82:675-84; PMID:7664346; http://dx.doi. org/10.1016/0092-8674(95)90039-X
21. Fotedar R, Bendjennat M, Fotedar A. Role of p21WAF1 in the cellular response to UV. Cell Cycle 2004; 3:134-7; PMID:14712074; http://dx.doi.org/ 10.4161/cc.3.2.658
22. Maeda T, Chong MT, Espino RA, Chua PP, Cao JQ, Chomey EG, Luong L, Tron VA. Role of p21(Waf-1) in regulating the G1 and G2/M checkpoints in ultravi-olet-irradiated keratinocytes. J Invest Dermatol 2002; 119:513-21; PMID:12190878; http://dx.doi.org/ 10.1046/j.1523-1747.2002.01828.x
23. Oh HS, Smart RC. Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol 1998; 110:939-45; PMID:9620302; http://dx. doi.org/10.1046/j.1523-1747.1998.00199.x
24. Swart GW, van Groningen JJ, van Ruissen F, Bergers M, Schalkwijk J. Transcription factor C/EBPalpha: novel sites of expression and cloning of the human gene. Biol Chem 1997; 378:373-9; PMID:9191024; http://dx.doi.org/10.1515/bchm.1997.378.5.373
25. Thompson EA, Zhu S, Hall JR, House JS, Ranjan R, Burr JA, He YY, Owens DM, Smart RC. C/EBPalpha expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPalpha confers susceptibility to UVB-induced skin squamous cell carcinomas. J Invest Dermatol 2011; 131:1339-46; PMID:21346772; http://dx.doi.org/10.1038/jid.2011.31
26. Yoon K, Smart RC. C/EBPalpha is a DNA damageinducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol 2004; 24:10650-60; PMID:15572670; http://dx.doi.org/ 10.1128/MCB.24.24.10650-10660.2004
27. Weissman BE, Aaronson SA. BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines. Cell 1983; 32:599-606; PMID:6297803; http://dx.doi.org/10.1016/0092-8674(83)90479-8
28. Ramirez A, Page A, Gandarillas A, Zanet J, Pibre S, Vidal M, Tusell L, Genesca A, Whitaker DA, Melton DW, et al. A keratin K5Cre transgenic line appropriate for tissue-specific or generalized Cre-mediated recombination. Genesis 2004; 39:52-7; PMID:15124227; http://dx.doi.org/10.1002/gene.20025
29. Hall JR, Kow E, Nevis KR, Lu CK, Luce KS, Zhong Q, Cook JG. Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage. Mol Biol Cell 2007; 18:3340-50; PMID:17567951; http://dx.doi. org/10.1091/mbc.E07-02-0173
30. Gokce E, Franck WL, Oh Y, Dean RA, Muddiman DC. In-Depth Analysis of the Magnaporthe oryzae Conidial Proteome. J Proteome Res 2012; 11:5827-35; PMID:23039028
31. Kall L, Canterbury JD,Weston J,NobleWS,MacCoss MJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods 2007; 4:923-5; PMID:17952086; http://dx.doi.org/10.1038/nmeth1113
32. Sistrunk C, Kim SH, Wang X, Lee SH, Kim Y, Macias E, Rodriguez-Puebla ML. Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation. Am J Pathol 2013; 182:1854-64; PMID:23474082; http://dx.doi.org/10.1016/j.ajpath.2013.01.016
33. Zhu S, Oh HS, Shim M, Sterneck E, Johnson PF, Smart RC. C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol Cell Biol 1999; 19:7181-90; PMID:10490653
34. Cmielova J, Rezacova M. p21Cip1/Waf1 protein and its function based on a subcellular localization; corrected. J Cell Bioch 2011; 112:3502-6; PMID:21815189; http://dx.doi.org/10.1002/ jcb.23296
35. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 1996; 10:804-15; PMID:8846917; http://dx.doi.org/ 10.1101/gad.10.7.804
36. Blank JL, Liu XJ, Cosmopoulos K, Bouck DC, Garcia K, Bernard H, Tayber O, Hather G, Liu R, Narayanan U, et al. Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. Cancer Res 2013; 73:225-34; PMID:23100467; http://dx.doi.org/10.1158/0008-5472.CAN-12-1729
37. Jia L, Li H, Sun Y. Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression. Neoplasia 2011; 13:561-9; PMID:21677879
38. Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes dev 2008; 22:2496-506; PMID:18794347; http://dx.doi.org/10.1101/ gad.1676108
39. Kim Y, Starostina NG, Kipreos ET. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev 2008; 22:2507-19; PMID:18794348; http://dx.doi.org/ 10.1101/gad.1703708
40. Nishitani H, Shiomi Y, Iida H, Michishita M, Takami T, Tsurimoto T. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem 2008; 283:29045-52; PMID:18703516; http://dx.doi.org/ 10.1074/jbc.M806045200
41. Abbas T, Dutta A. CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle 2011; 10:241-9; PMID:21212733; http://dx.doi.org/ 10.4161/cc.10.2.14530
42. Higa LA, Banks D, Wu M, Kobayashi R, Sun H, Zhang H. L2DTL/CDT2 interacts with the CUL4/ DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 2006; 5:1675-80; PMID:16861906; http://dx.doi.org/ 10.4161/cc.5.15.3149
43. Jin J, Arias EE, Chen J, Harper JW, Walter JC. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 2006; 23:709-21; PMID:16949367; http://dx.doi.org/10.1016/j. molcel.2006.08.010
44. Senga T, Sivaprasad U, ZhuW, Park JH, Arias EE, Walter JC, Dutta A. PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated N-terminal ubiquitination. J Biol Chem 2006; 281:6246-52; PMID:16407252; http://dx.doi.org/10.1074/jbc. M512705200
45. Abbas T, Shibata E, Park J, Jha S, Karnani N, Dutta A. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol Cell 2010; 40:9-21; PMID:20932471; http://dx.doi.org/10.1016/j.molcel.2010.09.014
46. Jorgensen S, Eskildsen M, Fugger K, Hansen L, Larsen MS, Kousholt AN, Syljuasen RG, Trelle MB, Jensen ON, Helin K, et al. SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. The J Cell Biol 2011; 192:43-54; PMID:21220508; http://dx.doi.org/10.1083/ jcb.201009076
47. Terai K, Shibata E, Abbas T, Dutta A. Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork progression after DNA damage. J Biol Chem 2013; 288:30509-14; PMID:24022480; http://dx.doi.org/ 10.1074/jbc.C113.505586
48. Abbas T, Mueller AC, Shibata E, Keaton M, Rossi M, Dutta A. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Mol Cell 2013; 49:1147-58; PMID:23478445; http://dx.doi.org/10.1016/j. molcel.2013.02.003
49. Nakagawa H, Tategu M, Yamauchi R, Sasaki K, Sekimachi S, Yoshida K. Transcriptional regulation of an evolutionary conserved intergenic region of CDT2-INTS7. PloS One 2008; 3:e1484; PMID:18213392; http://dx.doi.org/10.1371/journal.pone.0001484
50. Porse BT, Pedersen TA, Xu X, Lindberg B, Wewer UM, Friis-Hansen L, Nerlov C. E2F repression by C/ EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell 2001; 107:247-58; PMID:11672531; http://dx.doi.org/10.1016/S0092-8674(01)00516-5
51. Slomiany BA, D'Arigo KL, Kelly MM, Kurtz DT. C/ EBPalpha inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol 2000; 20:5986-97; PMID:10913181; http://dx.doi.org/ 10.1128/MCB.20.16.5986-5997.2000
52. Ando T, Kawabe T, Ohara H, Ducommun B, Itoh M, Okamoto T. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J Biol Chem 2001; 276:42971-7; PMID:11559705; http:// dx.doi.org/10.1074/jbc.M106460200
53. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282:1497-501; PMID:9822382; http:// dx.doi.org/10.1126/science.282.5393.1497
54. Chen J, Jackson PK, Kirschner MW, Dutta A. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 1995; 374:386-8; PMID:7885482; http://dx.doi.org/10.1038/374386a0